Introduction
Adrenocortical carcinoma (ACC) is a rare and aggressive malignancy with an annual incidence of 1–2 cases per million[1]. It frequently presents with advanced disease, and distant metastases most commonly involve the lungs, liver, bones, and lymph nodes[1]. Cardiac involvement is exceedingly uncommon and is typically associated with direct tumor extension through the inferior vena cava (IVC) into the right atrium[2].
Isolated left-sided cardiac metastases, particularly involving the left atrium or pulmonary veins, are exceptionally rare and pose diagnostic challenges[2–4]. Cardiac metastases may mimic primary cardiac tumors, such as atrial myxomas, potentially delaying diagnosis and carrying important clinical implications, especially in patients with systemic embolic events or cerebrovascular ischemia[5,6].HIGHLIGHTSCardiac metastasis of adrenocortical carcinoma is extremely rare.A left atrial mass mimicking a myxoma may present with a cardioembolic stroke.Early surgical intervention may be crucial to prevent recurrent embolization.
Herein, we present the case of a patient with a history of ACC who developed a left atrial mass mimicking a cardiac myxoma, along with left superior pulmonary vein (LSPV) involvement and cardioembolic stroke. To our knowledge, this constellation represents an exceptionally uncommon presentation of ACC metastasis. This case highlights the importance of multimodal imaging, differential diagnosis, and prompt surgical management to prevent further embolic complications and establish a definitive histopathological diagnosis.
This case has been reported in line with the SCARE 2025 criteria[7].
Case presentation
A 58-year-old woman presented to the emergency department at a tertiary care center with transient facial asymmetry and right upper extremity numbness, which resolved within 30 minutes. She had a history of hypertension, diabetes mellitus, and previously treated ACC, with irregular oncologic follow-up during the preceding year. Her regular medications included antihypertensive and antidiabetic therapy.
Non-contrast cranial computed tomography (CT) revealed no acute hemorrhage or mass effect, whereas diffusion-weighted brain magnetic resonance imaging (MRI) revealed multiple acute embolic infarcts involving the left cerebral hemisphere and the right periventricular region (Fig. 1A and B). As part of the initial evaluation, chest radiography was performed and demonstrated bilateral pulmonary nodular opacities (Fig.
1C). Given her oncologic history and these radiographic findings, thoracic CT was subsequently performed and revealed multiple bilateral pulmonary nodules consistent with metastatic disease (Fig. 1D).
Carotid CT angiography demonstrated patent extracranial vessels without significant stenosis. Figure 1.Multimodality imaging findings at initial presentation. (A) Apparent diffusion coefficient (ADC) map demonstrating acute embolic infarction in the left hemisphere.
(B) Diffusion-weighted magnetic-resonance-imaging (DWI) confirming diffusion restriction consistent with acute cerebral infarction. (C) Chest radiograph showing bilateral pulmonary nodular opacities. (D) Chest computed tomography demonstrating multiple bilateral pulmonary metastatic nodules.
(E) Transesophageal echocardiography (TEE) demonstrating two distinct left atrial masses.White arrows indicate the relevant imaging findings in panels A–D.
During etiological workup, transthoracic echocardiography (TTE) revealed two distinct left atrial masses: a well-circumscribed lesion adjacent to the interatrial septum and an irregular, mobile mass extending toward the LSPV. TEE confirmed that the second lesion originated from the LSPV (Fig. 2; Supplemental Digital Content Video S1, available at: https://links.lww.com/IJSCR/A183).
The lesion prolapsed into the left atrium during diastole and retracted into the LSPV during systole, raising concern for recurrent embolization and prompting early surgery (Supplemental Digital Content Figure S1, available at: https://links.lww.com/IJSCR/A181). Figure 2.Transesophageal echocardiographic evaluation of the left atrial masses. (A–D) Representative TEE images obtained in two imaging planes are shown.Panels A and B show the same imaging plane during systole and diastole, respectively, whereas panels C and D show a second imaging plane during systole and diastole, respectively.
The red arrows indicate a septum-attached mass with imaging features suggestive of cardiac myxoma, whereas the blue arrows indicate a second highly mobile left atrial mass originating from the LSPV.
Given the high risk of recurrent embolization, the patient underwent early surgery after preoperative preparation and optimization of comorbidities. Following median sternotomy, cardiopulmonary bypass (CPB) was established with systemic heparinization and bicaval cannulation, and myocardial arrest was achieved using del-Nido cardioplegia at moderate hypothermia. The right atrium was opened, and the left atrium was accessed via a transseptal incision around the fossa ovalis, providing exposure to the interatrial septum and left atrial cavity.
A vent catheter was inserted into the right superior pulmonary vein. Intraoperatively, a septum-attached mass mimicking a cardiac myxoma and a second friable lesion extending into the LSPV were identified, consistent with preoperative TEE findings (Fig. 3).
The septal mass was excised with a cuff of surrounding tissue, followed by piecemeal removal of the pulmonary vein lesion. A Fogarty catheter was advanced into the LSPV for intraluminal clearance until no additional material was retrieved. Figure 3.Intraoperative findings and excised tumor.
(A) Intraoperative view of the left atrium demonstrating two distinct tumor components, including a septal-based mass and a friable tumor extending toward the pulmonary vein. (B) Gross appearance of the excised tumor fragments after surgical removal.
The resulting atrial septal defect was reconstructed using an autologous pericardial patch, and the right atriotomy was closed primarily. After meticulous de-airing of the cardiac chambers, the aortic cross-clamp was removed, and the patient was gradually weaned from CPB. Cardiopulmonary bypass and aortic cross-clamp times were 49 and 36 minutes, respectively.
Following decannulation, hemostasis was achieved, thoracic drains and epicardial pacing wires were placed, and the sternum was closed with stainless-steel wires in standard fashion. The procedure was performed in a tertiary care center by an experienced cardiovascular surgical team. The procedure was completed as planned without any intraoperative deviation from the intended surgical strategy.
Histopathological examination of the resected left atrial and pulmonary venous masses revealed tumor infiltration within fibrin-rich thrombotic material (Supplemental Digital Content Figure S2A, available at: https://links.lww.com/IJSCR/A182). The tumor demonstrated solid nests and a trabecular/alveolar architecture consisting of cells with abundant eosinophilic cytoplasm and focal clear-cell change (Supplemental Digital Content Figure S2B–C, available at: https://links.lww.com/IJSCR/A182). The nuclei were round to oval with conspicuous nucleoli and mild-to-moderate pleomorphism.
Immunohistochemistry showed diffuse cytoplasmic positivity for calretinin and strong inhibin expression, supporting adrenocortical differentiation. Reticulin staining demonstrated disruption of the normal reticulin network, consistent with malignant adrenocortical neoplasm (Supplemental Digital Content Figure S2D–F, available at: https://links.lww.com/IJSCR/A182).
Histopathologic examination of both the left atrial and pulmonary venous specimens confirmed metastatic ACC. Further review of the patient’s previous oncologic records revealed that she had undergone right adrenalectomy approximately 6 years earlier for a hormonally active ACC. Preoperative evaluation demonstrated a large right adrenal mass associated with elevated DHEA-S levels and autonomous cortisol secretion.
The resected adrenal tumor measured 22.5 × 17.5 × 9 cm and was identified as high-grade (grade 3) ACC with necrosis and capsular invasion. Following a multidisciplinary tumor board evaluation, the patient received adjuvant radiotherapy and long-term mitotane therapy. According to the available medical records, mitotane treatment was continued for approximately 4 years but was subsequently discontinued due to drug-access issues.
The patient reported irregular oncologic follow-up during the year preceding her current presentation.
The postoperative course was uneventful, without perioperative or postoperative complications. The patient was discharged in good clinical condition on acetylsalicylic acid, according to institutional protocol. At the 6-month follow-up, the patient remained clinically stable, with no recurrent neurologic events.
TTE performed approximately 2.5 months after surgery demonstrated preserved left ventricular systolic function (ejection fraction, 65%), without evidence of a recurrent intracardiac mass. Subsequent oncologic evaluation confirmed persistent metastatic pulmonary disease. Follow-up PET/CT performed in April 2026 demonstrated a partial metabolic response, without evidence of newly developed lesions or disease progression (Table 1).
Table 1Timeline of clinical events.Time pointClinical event6 years before presentationRight adrenalectomy for hormonally active ACC followed by adjuvant radiotherapy and mitotane therapyPresentationTransient ischemic attack and intermittent hemoptysisDay 0Brain MRI demonstrated multiple acute embolic infarctsDay 1TTE and TEE identified two distinct left atrial masses, including a mobile pulmonary vein lesionPreoperative evaluationChest CT demonstrated multiple bilateral pulmonary metastatic nodulesSurgeryComplete excision of both left atrial masses with pulmonary vein clearance using a Fogarty catheterHistopathologyLeft atrial and pulmonary vein lesions confirmed metastatic adrenocortical carcinoma6-month follow-upNo recurrent neurologic events or intracardiac recurrence; PET/CT demonstrated partial metabolic response without disease progression
Discussion
Cardiac involvement in ACC is exceptionally rare and typically occurs by direct extension through the IVC into the right atrium rather than by hematogenous spread to the left heart[2,8]. Isolated left atrial metastases, particularly with pulmonary vein involvement, are therefore exceedingly uncommon[2–4].
In the present case, the septal mass closely mimicked cardiac myxoma on TTE and TEE, creating a diagnostic challenge in distinguishing metastatic cardiac involvement from a primary cardiac tumor[5,6]. Myxomas typically arise near the fossa ovalis and appear as mobile, pedunculated masses[5], both of which were observed in our patient. However, the second lesion extending into the pulmonary vein, together with the oncologic history and systemic metastases, strongly supported a metastatic etiology rather than a primary cardiac tumor.
The differential diagnosis of a left atrial mass includes myxoma, thrombus, primary malignant cardiac tumors, infective vegetations, and metastatic lesions. Thrombus was considered unlikely, given the absence of atrial fibrillation and the presence of two distinct masses, including one extending into the LSPV. Although primary malignant cardiac tumors such as sarcomas may also present as left atrial masses, the patient’s history of malignancy, pulmonary vein involvement, and concomitant metastatic lesions strongly supported a metastatic etiology.
The marked cyclical mobility of the pulmonary vein lesion observed on TEE is of particular interest. Such repetitive motion may increase mechanical stress on the friable tumor surface, potentially facilitating tumor fragmentation and systemic embolization[2,5,6]. In our patient, multiple acute cerebral infarcts on diffusion-weighted MRI and the mobile pulmonary vein–prolapsing mass on TEE supported a cardioembolic mechanism.
Pulmonary vein involvement may further increase the risk of recurrent embolization by allowing tumor fragments to enter the systemic circulation[2,4]. Accordingly, prevention of further embolization was the primary indication for early surgery.
Despite metastatic pulmonary disease, surgical intervention was considered justified by the high embolic risk and the inability of preoperative imaging to reliably distinguish metastatic disease from a primary cardiac tumor. Surgical excision, therefore, served both therapeutic and diagnostic purposes by preventing further embolization and establishing a definitive histopathological diagnosis. Given the patient’s preserved functional status and absence of prohibitive surgical risk factors, a multidisciplinary team favored operative management despite the underlying metastatic malignancy.
Surgical resection of cardiac metastases is generally palliative but may be indicated for symptom relief, prevention of embolization, restoration of intracardiac flow, and definitive histopathological diagnosis[2,3,9]. In selected patients with life-threatening complications, such as stroke, aggressive surgical management can be justified even in disseminated malignancy. In this case, complete excision of both lesions, reconstruction of the interatrial septum with an autologous pericardial patch, and intraluminal clearance of the LSPV using a Fogarty catheter were performed to minimize residual tumor burden and embolic risk.
The use of a Fogarty catheter for intraluminal clearance of the LSPV was an important technical aspect of the procedure. Because preoperative imaging suggested tumor extension into the left pulmonary vein, simple excision of the intracardiac component alone might have left residual tumor burden. Gentle advancement of the catheter allowed removal of friable intraluminal tumor material while preserving the integrity of the pulmonary vein.
However, this maneuver should be performed cautiously because excessive traction or aggressive manipulation could theoretically increase the risk of endothelial injury, bleeding, pulmonary vein damage, or tumor fragmentation. The transseptal approach via a right atriotomy provided adequate exposure of both lesions. En bloc excision of the septal mass and meticulous clearance of the LSPV were essential, given the friable nature of the tumor.
In the present case, the procedure was completed without technical complications and facilitated satisfactory clearance of the involved vein.
Histopathological evaluation established the definitive diagnosis. The tumor demonstrated solid nests with trabecular and alveolar architecture composed of cells with abundant eosinophilic cytoplasm and focal clear-cell change, consistent with ACC morphology[1,10]. Immunohistochemical analysis showed diffuse calretinin positivity and strong inhibin expression, supporting adrenocortical differentiation[10,11].
Reticulin staining revealed disruption of the normal reticulin network, a defining feature of malignant adrenocortical neoplasms and a key component of the reticulin algorithm[12]. These findings confirmed metastatic ACC rather than a primary cardiac tumor, with important therapeutic and prognostic implications[2,6].
This case highlights the importance of multimodal imaging in patients with malignancy who present with embolic events, enabling accurate localization of the embolic source. Awareness that metastatic disease can masquerade as an atrial myxoma is critical for cardiologists, radiologists, and cardiothoracic surgeons.
Left atrial metastases are rare and usually associated with advanced disease or contiguous spread, often being diagnosed incidentally or presenting with obstructive symptoms[13]. Cardiac metastases presenting with embolic stroke are particularly uncommon and have mainly been reported in cases of tumors extending into the left atrium through the pulmonary veins, particularly in renal cell carcinoma and lung cancer[14–16]. In contrast, cardiac involvement in ACC typically occurs by direct extension through the IVC into the right atrium, rather than by hematogenous spread to left-sided cardiac chambers[2,17,18].
Unlike these typical patterns, our patient presented with acute cardioembolic stroke associated with a mobile pulmonary vein–prolapsing lesion, representing an exceptionally rare presentation of left atrial ACC metastasis. The coexistence of a myxoma-like septal mass and a second lesion extending into the LSPV further complicated the diagnostic distinction between a primary cardiac tumor and metastatic disease.
In our patient, the absence of recurrent embolic events supports the effectiveness of surgical management, although the prognosis remains guarded given the presence of systemic metastases. The main strength of this case lies in its rare presentation and the use of multimodal imaging, combined with successful surgical management, while the main limitation is the short follow-up period, which precludes assessment of long-term outcomes.
Conclusion
This case illustrates a rare presentation of ACC as a left atrial mass mimicking cardiac myxoma with pulmonary vein involvement and cardioembolic stroke. Cardiac metastasis should be considered in patients with ACC presenting with intracardiac masses or embolic events. Multimodal imaging is essential for diagnosis and surgical planning, while early surgical resection may prevent recurrent embolization and enable definitive histopathological diagnosis.
Increased awareness of this rare presentation may facilitate timely diagnosis and appropriate management in similar clinical scenarios.